CASE REPORT
MYT1L mutation in a patient with severe early-onset obesity and intellectual disability
1
Hospital Santa Luzia, Portugal 2Hospital Pedro Hispano, Portugal
Submission date: 2023-11-21
Final revision date: 2024-01-02
Acceptance date: 2024-01-07
Publication date: 2024-06-21
Pediatr Pol 2024;99(2):164-166
KEYWORDS
TOPICS
ABSTRACT
Children suffering from intellectual disability, dysmorphic features and organ-specific developmental abnormalities should undergo genetic testing. Entities such as X fragile syndrome should be investigated. If we add obesity to the “equation”, Prader-Willi and Bardet-Biedl are thus far the most common syndromic conditions to be found. The evolution of genetic testing brought several other genetic determinants of developmental delay. We report on a 4-year-old girl presenting with obesity and delayed neurological, cognitive and motor development whose genetic testing by array-based comparative genomic hybridization exposed a partial deletion at chromosome 2p25.3, containing the gene MYT1L.
REFERENCES (10)
1.
Vasudevan P, Suri M. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond) 2017; 17: 558-561.
2.
Mithyantha R, Kneen R, McCann E, Gladstone M. Current evidence-based recommendations on investigating children with global developmental delay. Arch Dis Child 2017; 102: 1071-1076.
3.
Di Cesare M, Sorić M, Bovet P, et al. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med 2019; 17: 212.
4.
Huvenne H, Dubern B, Clément K, Poitou C. Rare genetic forms of obesity: clini-cal approach and current treatments in 2016. Obes Facts 2016; 9: 158-173.
5.
Kaur Y, de Souza RJ, Gibson WT, Meyre D. A systematic review of genetic syndromes with obesity. Obes Rev 2017; 18: 603-634.
6.
Stevens SJC, van Ravenswaaij-Arts CMA, Janssen JWH, et al. MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions. Am J Med Genet Part A 2011; 155: 2739-2745.
7.
Carvalho LML, D’Angelo CS, Mustacchi Z, et al. A novel MYT1L mutation in a boy with syndromic obesity: Case report and literature review. Obes Res Clin Pract 2021; 15: 124-132.
8.
Loid P, Mäkitie R, Costantini A, Viljakainen H, Pekkinen M, Mäkitie O. A novel MYT1L mutation in a patient with severe early-onset obesity and intellectual disability. Am J Med Genet A 2018; 176: 1972-1975.
9.
Blanchet P, Bebin M, Bruet S, et al. MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus. PLoS Genet 2017; 13: e1006957.
10.
Coursimault J, Guerrot AM, Morrow MM, et al. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Hum Genet 2022; 141: 65-80.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
